Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
287 hedge funds and large institutions have $5.07B invested in Abiomed Inc in 2017 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 114 increasing their positions, 97 reducing their positions, and 40 closing their positions.
169% more call options, than puts
Call options by funds: $25.5M | Put options by funds: $9.47M
18% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 97
9% more capital invested
Capital invested by funds: $4.67B → $5.07B (+$400M)
8% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 40
3% less funds holding
Funds holding: 297 → 287 (-10)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$376M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$126M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$24.8M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$22M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$150M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$71.7M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$52.4M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$35.1M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$23.8M |
ABMD Hedge Fund Activity: Q1 2017 in Review
287 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2017, worth a combined $5.07B — up 8.6% from $4.67B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of ABMD and 37 opened new positions — a net loss of 3 holders — while 97 trimmed existing stakes and 114 added.
The largest buyer was BlackRock, adding an estimated $376M. The largest seller was 1832 Asset Management, cutting an estimated $150M.
- 287 institutional investors held Abiomed Inc (ABMD) as of Q1 2017, down from 297 in Q4 2016.
- Funds reported $5.07B of Abiomed Inc stock for Q1 2017, up 8.6% quarter-over-quarter.
- 37 funds opened new Abiomed Inc positions in Q1 2017 and 40 closed out, a net change of -3 holders.
- The largest Abiomed Inc buyer in Q1 2017 was BlackRock, an estimated $376M added.
- The largest Abiomed Inc seller in Q1 2017 was 1832 Asset Management, an estimated $150M sold.
Based on aggregated 13F filings for Q1 2017.